Director/Senior Director, Regulatory Affairs, Pulmovant
Pulmovant
About this role
Pulmovant, a clinical-stage biotechnology company focused on pulmonary diseases, develops innovative inhaled therapies such as mosliciguat for pulmonary hypertension. The company emphasizes collaboration, scientific innovation, and advancing its pipeline through clinical trials and regulatory success.
Skills
About Pulmovant
pulmovant.comPulmovant is a clinical-stage biopharmaceutical company focused on developing inhaled therapies for respiratory infections and chronic lung diseases. Using pulmonary-delivery expertise and proprietary formulation approaches, the company aims to concentrate active agents in the lung to boost local efficacy while minimizing systemic exposure. Pulmovant advances a pipeline of inhaled antibacterial and antiviral candidates through preclinical and clinical development and seeks strategic partnerships to bring new pulmonology medicines to patients.
Recent company news
The Clinical Trial VanguardPulmovant Completes Enrollment for Phase 2 PH-ILD Study
1 month ago
GlobeNewswirePulmovant Announces Completion of Enrollment in the Phase 2
1 month ago
GlobeNewswirePulmovant Receives Orphan Drug Designation in Japan for
Sep 4, 2025
Investing.comPulmovant completes enrollment for PH-ILD treatment trial
1 month ago
STATRoivant acquires drug for pulmonary hypertension from Bayer
Sep 10, 2024
About Pulmovant
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Pulmovant.
Salary
$130k – $180k
per year